Hofseth BioCare ASA Logo

Hofseth BioCare ASA

ISIN: NO0010598683 | Ticker: HBC | LEI: 5967007LIEEXZXGGEO44

About Hofseth BioCare ASA

Company Description

Our mission is to explore the medical and pharmaceutical potential in compounds from our products, derived from an innovative hydrolysis technology. In the years to come we are confident – and research from some of the world leading university and hospitals clearly indicates – that our technology could become the basis of tomorrow's medicine.

In addition to the potential in becoming the medicine of tomorrow, HBC has an established industry that develops high-value ingredients and finished products for the nutrition market. Our products are present in 40 different countries throughout the world.

The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources.

Hofseth BioCare's headquarters are in Ålesund, Norway with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Year founded

2000

Served area

Worldwide

Headquarters

Kipervikgata 13, 6003 Ålesund – Norway

Filings & Publications

2021

Report Q1 H1 Q3 FY
Consolidated Report no
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

395,081,030

IPO

Jan. 1, 2000

Stock exchange(s)

Euronext Oslo

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.